GMW Bioscience, a Contract Research Organization (CRO) specializing in efficacy trials, biostimulants, and agribiotechnology services, has officially joined the Tentamus Group. As a trusted expert partner, GMW Bioscience supports its clients by conducting controlled and field trials covering efficacy, biostimulant, and biological control products, providing the science and data necessary for regulatory processes to bring […]
Read More
The Tentamus Group is pleased to announce that David Biacsi-Schoen will join the company effective March 1, 2026, assuming the dual roles of Head of Group IT and Director IT DACH. In his role as Director IT DACH, David will lead the prioritisation and delivery of regional IT initiatives across the DACH organization, ensuring close […]
Read More
We’re pleased to announce that Eva-Aster de Gier will be appointed Chief Operating Officer (COO) effective March 1, 2026. Eva-Aster previously served as Tentamus’ Director of Operations, where she played a pivotal role in building our operational excellence network, modernizing core operational processes, and positioning the organization for efficiency and scalability. In her new role, […]
Read More
Laemmegroup Laboratory has initiated a major operational expansion aimed at delivering an even more efficient, faster, and more reliable service to its clients. The entire operational workflow has been comprehensively redesigned, from sample receipt through to the issuance of analytical results. Collaboration between sample reception and the laboratory sample preparation department has been streamlined and […]
Read More
Bioanalytical control of biological drug substances is performed at VelaLabs using new capillary electrophoresis sodium dodecyl sulphate (CE-SDS) and capillary isoelectric focusing (cIEF) technology for charge and size analysis. In 2025, VelaLabs (Vienna) performed multiple assay developments for monoclonal antibodies to analyse their size and charge – either reduced or non-reduced. The Maurice device from […]
Read More
Professional excellence does not come from knowledge alone, but from people who share, question and develop their knowledge together. With this in mind, the teams at TentaConsult Pharma & Med GmbH gathered for their annual winter meeting on 22 and 23 January 2026. The two-day meeting was dedicated to exchange, reflection and personal encounters. The […]
Read More
Fachliche Exzellenz entsteht nicht allein durch Wissen, sondern durch Menschen, die ihr Wissen teilen, hinterfragen und gemeinsam weiterentwickeln. Vor diesem Hintergrund haben sich die Teams der TentaConsult Pharma & Med GmbH am 22. und 23. Januar 2026 zum jährlichen Wintermeeting zusammengefunden. Das zweitägige Treffen stand im Zeichen von Austausch, Reflexion und persönliche Begegnung. Ziel war […]
Read More
Tentamus UK celebrated its 10-year anniversary last year, marking a decade of delivering high-quality laboratory testing and scientific services to regulated industries across the United Kingdom. Founded with QTS Analytical – A Tentamus Company, Tentamus UK has since grown to include six additional specialised laboratories, reflecting a decade of strategic expansion and investment in providing […]
Read More
The Tentamus Group announces the entry of Techno Analisys into its network of specialized companies and laboratories in Italy, effective January 1, 2026. This transaction is part of the Group’s growth strategy aimed at strengthening its presence in the Italian market and further expanding its portfolio of high value-added services. Techno Analisys is a laboratory […]
Read More
What Is Cereulide? Cereulide is a heat-stable toxin produced by the bacterium Bacillus cereus. Because it survives cooking and reheating, it represents a significant risk to food safety and may cause adverse health effects in ready-to-eat products. Occurrence of Bacillus cereus in Food Products Bacillus cereus is naturally present in the environment, including soil, […]
Read More